FFCP PHASE2:Hg19::chr10:103912137..103912159,+
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p1@NOLC1 |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_1_at_NOLC1_5end |
| Coexpression cluster: | C2971_Mast_rhabdomyosarcoma_osteosarcoma_hepatoblastoma_malignant_acute_hepatocellular |
| Association with transcript: | 0bp_to_ENST00000488254_5end |
| EntrezGene: | NOLC1 |
| HGNC: | 15608 |
| UniProt: | NA |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p1@NOLC1 |
|---|
0
100
200
300
400
500
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| cancer | 3.01e-53 | 235 |
| disease of cellular proliferation | 1.97e-51 | 239 |
| cell type cancer | 3.99e-29 | 143 |
| carcinoma | 1.94e-25 | 106 |
| organ system cancer | 3.99e-23 | 137 |
| hematologic cancer | 2.13e-20 | 51 |
| immune system cancer | 2.13e-20 | 51 |
| leukemia | 5.95e-17 | 39 |
| myeloid leukemia | 3.97e-13 | 31 |
| squamous cell carcinoma | 3.25e-07 | 14 |
Showing 1 to 10 of 10 entries
